Nonenveloped capsid: Mechanisms of viral entry

Future Virology

Volumn 9, Issue 12, 2014, Pages 1105-1121

  Lins, Bridget ^a   Agbandje Mckenna, Mavis ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

entry mechanisms; internalization; membrane breach factors; nonenveloped viruses; receptors

Indexed keywords

ADENOVIRIDAE; CHANNEL GATING; CYTOPLASM VESICLE; CYTOSOL; MYOVIRIDAE; NONHUMAN; PAPILLOMA VIRUS; PARVOVIRIDAE; PICORNAVIRIDAE; PODOVIRIDAE; POLYOMA VIRUS; PROKARYOTIC CELL; REOVIRIDAE; REVIEW; SIPHOVIRIDAE; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; EUKARYOTA; MICROVIRIDAE; MIRIDAE; MYOVIRIDAE; PAPILLOMAVIRIDAE; PARVOVIRIDAE; PICORNAVIRIDAE; PODOVIRIDAE; POLYOMAVIRIDAE; PROKARYOTA; REOVIRIDAE; SIPHOVIRIDAE;

EID: 84919790421     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.14.82     Document Type: Review

References (242)

1. Freimuth P, Springer K, Berard C, Hainfeld J, Bewley M, Flanagan J. Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J. Virol. 73(2), 1392-1398 (1999).
2. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77(17), 9183-9191 (2003).
3. Zhang Y, Bergelson JM. Adenovirus receptors. J. Virol. 79(19), 12125-12131 (2005).
4. Bhella D, Goodfellow IG. The cryo-electron microscopy structure of feline calicivirus bound to junctional adhesion molecule a at 9-angstrom resolution reveals receptorinduced flexibility and two distinct conformational changes in the capsid protein VP1. J. Virol. 85(21), 11381-11390 (2011).
5. Makino A, Shimojima M, Miyazawa T, Kato K, Tohya Y, Akashi H. Junctional adhesion molecule 1 is a functional recept or for feline calicivirus. J. Virol. 80(9), 4482-4490 (2006).
6. Stuart AD, Brown TDK. 2,6-Linked sialic acid acts as a receptor for Feline calicivirus. J. Gen. Virol. 88(1), 177-186 (2007).
7. Taube S, Perry JW, McGreevy E et al. Murine noroviruses bind glycolipid and glycoprotein attachment receptors in a strain-dependent Manner. J. Virol. 86(10), 5584-5593 (2012).
8. Taube S, Perry JW, Yetming K et al. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 83(9), 4092-4101 (2009).
9. Misinzo G, Delputte P, Meerts P, Lefebvre D, Nauwynck H. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate b glycosaminoglycans as receptors for its attachment to host cells. J. Vi rol. 80(7), 3487-4394 (2006).
10. Sapp M, Bienkowska-Haba M. Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus: HPV entry. FEBS J. 276(24), 7206-7216 (2009).
11. Schiller JT,Day PM,Kines RC Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 118 1), S12-S17 2010).
12. Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80(19), 9831-9836 (2006).
13. Ka shiwakura Y, Tamayose K, Iwabuchi K et al. Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J. Virol. 79(1), 609-614 (2005).
14. Summerford C, Samulski RJ. Membraneassociated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72(2), 1438-1445 (1998).
15. Halder S, Cotmore S, Heimburg-Molina ro J et al. Profiling of glycan receptors for minute virus of mice in permissive cell lines towards understanding the mechanism of cell recognition. PLoS ONE 9(1), e86909 (2014).
16. Summerford C, Bartlet t J, Samulski RJ. V5 integrin: a co-receptor for adenoassociated virus type 2 infection. Nat. Med. 5(1), 78-82 (1999).
17. He Y, Chipman PR, Howitt J et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Mol. Biol. 8(10), 874-878 (2001).
18. He wat EA, Neumann E, Conway JF et al. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view. EMBO J. 19(23), 6317-6325 (2000).
19. Me ndelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56(5), 855-865 (1989).
20. Ruiz-Sáenz J, Goez Y, Tabares W, López-Herrera A. Cellular receptors for foot and mouth disease virus. Intervirology 52(4), 201-212 (2009).
21. Shafren DR, Bates RC, Ag rez MV, Herd RL, Burns GF, Barry RD. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69(6), 3873-3877 (1995).
22. Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW. Decayaccelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13(21), 5070 (1994).
23. Campanero-Rhodes MA, Smith A, Chai W et al. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 81(23), 12846-12858 (2007).
24. Gilbert J, Benjamin T. Uptake pathway of polyomavirus via ganglioside GD1a. J. Virol. 78(22), 12259-12267 (2004).
25. Smith AE, Lilie H, Helenius A. Gangliosidedependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett. 555(2), 199-203 (2003).
26. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA. Gangliosides are receptors for murine polyomavirus and SV40. EMBO J. 22(17), 4346-4355 (2003).
27. Barton ES, Forrest JC, Connolly JL et al. Junction adhesion molecule is a receptor for reovirus. Cell 104(3), 441-451 (2001).
28. Forrest JC, Dermody TS. Reovirus receptors and pathogenesis. J. Virol. 77(17), 9109-9115 (2003).
29. Fleming FE, Boh m R, Dang VT et al. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and 2 1 integrin in mediating rotavirus infection. J. Virol. 88(8), 4558-4571 (2014).
30. Reiss K, Stencel JE, Liu Y et al. The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog. 8(12), e1003078 (2012).
31. Xia G, Corrigan RM, Winstel V, Goerke C, Grundling A, Peschel A. Wall teichoic acid-dependent adsorption of staphylococcal siphovirus and myovirus. J. Bacteriol. 193(15), 4006-4009 (2011).
32. Rakhuba DV,Kolomiets EI,Dey ES,Novik GI Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol. J. Microbiol. 59(3 145-155 2010).
33. Lindberg AA. Bacteriophage receptors. Annu. Rev. Microbiol. 27(1), 205-241 (1973).
34. Bartell P, Orr T, Reese J, Imadeda T. Interaction of Pseudomonas bacteriophage 2 with the slime polysaccharide and lipopolysaccharide of Pseudomonas aeruginosa strain BI. J. Virol. 8(3), 311-317 (1971).
35. Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use alpha v integrins for infection. J. Virol. 68(10), 6811-6814 (1994).
36. Meier O, Boucke K, Vig Hammer S et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158(6), 1119-1131 (2002).
37. Amstutz B, Gastaldelli M, Kälin S et al. Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J. 27(7), 956-969 (2008).
38. Johnson JE. Cell Entry by Non-Enveloped Viruses. Springer Berlin Heidelberg, Berlin, Germany (2010).
39. Medina-Kauwe LK. Endocytosis o f adenovirus and adenovirus capsid proteins. Adv. Drug Deliv. Rev. 55(11), 1485-1496 (2003).
40. Maier O, Galan DL, Wodrich H, Wiethoff CM. An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 402(1), 11-19 (2010).
41. Moyer CL, Nemerow GR. Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses. Curr. Opin. Virol. 1(1), 44-49 (2011).
42. Tsai B. Penetration of nonenveloped viruses into the cytoplasm. Annu. Rev. Cell Dev. Biol. 23(1), 23-43 (2007).
43. Wickham T, Mathias P, Cheresh D, Nemerow G. Integrins alphavbeta3 and alphavbeta5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
44. Bewley MC, Springer K, Zhang Y-B, Freimuth P, Flanagan J. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286(5444), 1579-1583 (1999).
45. Moyer CL, Wiethoff CM, Maier O, Smith JG, Nemerow GR. Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J. Virol. 85(6), 2631-2641 (2011).
46. Greber UF, Willetts M, Webster P, Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75(3), 477-486 (1993).
47. Wiethoff CM, Wodrich H, Gera ce L, Nemerow GR. Adenovirus protein vi mediates membrane disruption following capsid disassembly. J. Virol. 79(4), 1992-2000 (2005).
48. Suomalainen M, Luisoni S, Boucke K, Bianchi S, Engel DA, Greber UF. A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J. Virol. 87(22), 12367-12379 (2013).
49. Imelli N, Meier O, Boucke K, Hemmi S, Greber UF. Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. J. Virol. 78(6), 3089-3098 (2004).
50. Pietiä inen VM, Marjomäki V, Heino J, Hyypiä T. Viral entry, lipid rafts and caveosomes. Ann. Med. 37(6), 394-403 (2005).
51. Day PM, Lowy DR, Schiller JT. Papillomaviruses infect cells via a clathrindependent pathway. Virology 307(1), 1-11 (2003).
52. Bousarghin L, Touze A, Sizaret P-Y, Coursaget P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77(6), 3846-3850 (2003).
53. Smith JL, Campos SK, Wandinger-Ness A, Ozbun MA. Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-depend ent uncoating. J. Virol. 82(19), 9505-9512 (2008).
54. Kamper N,Day PM,Nowak T,et al A membrane-destabilizing peptide in capsid protein l2 is required for egress of papillomavirus genomes from endosomes J. Virol. 80 2 759-768, 2006).
55. Bergant Maru͉i M, Ozbun MA, Campos SK, Myers MP, Banks L. Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17: HPVL2 and SNX17. Traffic 13(3), 455-467 (2012).
56. Horvath CA, Boulet GA, Renoux VM, Delvenne PO, Bogers JP. Mechanisms of cell entry by human papillomaviruses: an overview. Virol. J. 7(11) (2010).
57. O'Donnell J, Tayl or KA, Chapman MS. Adeno-associated virus-2 and its primary cellular receptor-Cryo-EM structure of a heparin complex. Virology 385(2), 434-443 (2009).
58. Levy HC, Bowman VD, Govindasamy L et al. Heparin binding induces conformational changes in Adeno-associated virus serotype 2. J. Struct. Biol. 165(3), 146-156 (2009).
59. Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74(6), 2777-2785 (2000).
60. Bantel-Schaal U, Braspenning-Wesch I, Kartenbeck J. Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts. J. Gen. Virol. 90(2), 317-322 (2009).
61. Nonnenmacher M, We ber T. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 10(6), 563-576 (2011).
62. Zádori Z, Szelei J, Lacoste M-C et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1(2), 291-302 (2001).
63. Liu Y, Joo KI, Wang P. Endocytic processing of adeno-associated virus type 8 vectors for transduction of target cells. Gene Ther. 20(3), 308-317 (2012).
64. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infe ction by adeno-associated virus 2. Nat. Med. 5(1), 71-77 (1999).
65. Asokan A, Hamra JB, Govindasamy L, Agbandje-McKenna M, Samulski RJ. Adeno-associated virus type 2 contains an integrin alph a5 beta1 binding domain essential for viral cell entry. J. Virol. 80(18), 8961-8969 (2006).
66. Di Pasquale G, Davidson B, Stein C et al. Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9(10), 1306-1312 (2003).
67. Walters RW, Yi SMP, Keshavjee S et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Ch em. 276(23), 20610-20616 (2001).
68. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. 2,3 and 2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80(18), 9093-9103 (2006).
69. Stahnke S, Lux K, Uhrig S et al. Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology 409(1), 77-83 (2011).
70. Canaan S, Zadori Z, Ghomashchi F et al. Interfacial enzymology of parvovirus phospholipases A2. J. Biol. Chem. 279(15), 14502-14508 (2004).
71. Parker J, Parrish C. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 74(4), 1919-1930 (2000).
72. Suikkanen S, Antila M, Jaatinen A, Vihinen-Ranta M, Vuento M. Release of canine parvovirus from endocytic vesicles. Virology 316(2), 267-280 (2003).
73. Lopez-Bueno A, Rubio M-P, Bryant N, McKenna R, Agbandje-McKenna M, Almendral JM. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and dete rmine virulence. J. Virol. 80(3), 1563-1573 (2006).
74. Mani B, Baltzer C, Valle N, Almendral JM, Kempf C, Ros C. Low pH-dependent endosomal processing of the incoming parvovirus minu te virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome. J. Virol. 80(2), 1015-1024 (2006).
75. Ros C,Burckhardt C J,Kempf C Cytoplasmic trafficking of minute virus of mice: low-ph requirement, routing to late endosomes, and proteasome interaction J. Virol. 76 24 12634-12645 2002).
76. Chung S-K, Kim J-Y, Kim I-B, Park S-I, Paek K-H, Nam J-H. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 333(1), 31-40 (2005).
77. Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124(1), 119-131 (2006).
78. Coyne CB, Shen L, Turner JR, Bergelson JM. Coxsa ckievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2(3), 181-192 (2007).
79. Triantafilou K, Triantafilou M. Lipid raft microdomains: key sites for Coxsackievirus A9 infectious cycle. Virology 317(1), 128-135 (2003).
80. Triantafilou K, Triantafilou M. Lipid-raftdependent Coxsackievirus B4 internalization and rapid targeting to the Golgi. Virology 326(1), 6-19 (2004).
81. Shieh JTC, Bergelson JM. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J. Virol. 76(18), 9474-9480 (2002).
82. O'Donnell V, LaRocco M, Duque H, Baxt B. Analysis of foot-and-mouth disease virus internalization events in cultured cells. J. Virol. 79(13), 8506-8518 (2005).
83. O'Donnell V, LaRocco M, Baxt B. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J. Virol. 82(18), 9075-9085 (2008).
84. Jackson T, Blakemore W, Newman JW et al. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin 51: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J. Gen. Virol. 81(5), 1383-1391 (2000).
85. Chow M, Newman JFE, Filman D, Hogle JM, Rowlands DJ, Brown F. Myristylation of picornavirus capsid protein VP4 and its str uctural significance. Nature 327, 482-486 (1987).
86. Fuchs R, Blaas D. Uncoating of human rhinoviruses. Rev. Med. Virol. 20(5), 281-297 (2010).
87. Vlasak M, Goesler I, Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J. Virol. 79(10), 5963-5970 (2005).
88. Weiss VU, Bile k G, Pickl-Herk A et al. Liposomal leakage induced by virus-derived peptides, viral proteins, and entire virions: rapid analysis by chip electrophoresis. Anal. Chem. 82(19), 8146-8152 (2010).
89. Be lnap D, McDermott B, Filman D et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc. Natl Acad. Sci. USA 97(1), 73-78 (2000).
90. Coyne CB, Kim K, Bergelson J.Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J. 26(17), 4016-4028 (2007).
91. Bergelson JM. New (fluorescent) light on poliovirus entry. Trends Microbiol. 16(2), 44-47 (2008).
92. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. Imaging poliovirus entry in live cells. PLoS Biol. 5(7), e183 (2007).
93. Bubeck D, Filman DJ, Cheng N, Steven AC, Hogle JM, Belnap DM. The structure of the poliovirus 135s cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J. Virol. 79(12 ), 7745-7755 (2005).
94. Fricks CE, Hogle JM. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64(5), 1934-1945 (1990).
95. Paul AV, Schultz A, Pincus SE, Oroszlan S, Wimmer E. Capsid protein VP4 of poliovirus is N-myristoylated. Proc. Natl Acad. Sci. USA 84(22), 7827-7831 (1987).
96. Kaplan G,Freistadt MS,Racaniello VR Neutralization of poliovirus by cell receptors expressed in insect cells J. Virol. 64 10 4697-4702 1990).
97. Belnap DM, Filman DJ, Trus BL et al. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J. Virol. 74(3), 1342-1354 (2000).
98. Perez L, Carrasco L. Ent ry of poliovirus into cells does not require a low-pH step. J. Virol. 67(8), 4543-4548 (1993).
99. Arita M, Koike S, Aoki J, Horie H, Nomoto A. Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J. Virol. 72(5), 3578-3586 (1998).
100. Danthi P, Tosteson M, Li QH, Chow M. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J. Virol. 77(9), 5266-5274 (2003).
101. Tosteson M, Wang H, Naumov A, Chow M. Poliovirus binding to its receptor in lipid bilayers results in particle-specific, temperature-sensitive channels. J. Gen. Virol. 85(6), 1581-1589 (2004).
102. Richterova Z, Liebl D, Horak M et al. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 Pseudocapsids toward Cell Nuclei. J. Virol. 75(22), 10880-10891 (2001).
103. Liebl D, Difato F, Hornikova L, Mannova P, Stokrova J, Forstova J. Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab 11-positive endosomes. J. Virol. 80(9), 4610-4622 (2006).
104. Rainey-Barger EK, Magnuson B, Tsai B. A chaperone-activated nonenveloped virus perforates the physiologically relevant endoplasmic r eticulum membrane. J. Virol. 81(23), 12996-13004 (2007).
105. Gilbert JM, Goldberg IG, Benjamin TL. Cell penetration and trafficking of polyomavirus. J. Virol. 77(4), 2615-2622 (2003).
106. Qian M, Cai D, Verhey KJ, Tsai B. A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Pathog. 5(6), e1000465 ( 2009).
107. Stehle T, Yan Y, Benjamin T, Harrison S. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 368, 160-163 (1994).
108. Ne u U, Woellner K, Gauglitz G, Stehle T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl Acad. Sci. USA 105(13), 5219-5224 (2008).
109. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3, 473-483 (2001).
110. Kuksin D, Norkin LC. Disassembly of simian virus 40 during passage through the endoplasmic reticulum and in the cytoplasm. J. Virol. 86(3), 1555-1562 (2012).
111. Damm E-M, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Heleniu s A. Clathrin-and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168(3), 477-488 (2005).
112. Daniels R, Rusan NM, Wilbuer A-K, Nork in LC, Wadsworth P, Hebert DN. Simian virus 40 late proteins possess lytic properties that render them capable of permeabilizing cellular membranes. J. Virol. 80(13), 6575-6587 (2006).
113. Daniels R, Rusan NM, Wadsworth P, Hebert DN. SV40 VP2 and VP3 insertion into ER membranes is controlled by the Capsid protein VP1: implications for DNA translocation out of the ER. Mol. Cell. 24(6), 955-966 (2006).
114. Streuli C, Griffin B. Myristic acid is coupled to a structural protein of polyomavirus and SV40. Nature 326, 619-622 (1987).
115. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J. Virol. 66(4), 2037-2045 (1992).
116. P elkmans L, Puntener D, Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296(5567), 535-539 (2002).
117. Ehrlich M, Boll W, van Oijen A et al. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118(5), 591-605 (2004).
118. Zhang L,Agosto MA,Ivanovic T,King DS,Nibert ML,Harrison SC Requirements for the formation of membrane pores by the reovirus myristoylated 1N peptide J. Virol. 83 14 7004-7014 2009).
119. Campbell JA, Schelling P, Wetzel JD et al. Junctional adhesion molecule A serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J. Virol. 79(13), 7967-7978 (2005).
120. Maginnis MS, Forrest JC, Kopecky-Bromberg SA et al. 1 Integrin mediates internalization of mammalian reovirus. J. Virol. 80(6), 2760-2770 (2006).
121. Sturzenbecker LJ, Nibert M, Furlong D, Fields BN. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61(8), 2351-2361 (1987).
122. Baer GS, Dermody TS. Mutations in reovirus outer-cap sid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J. Virol. 71(7), 4921-4928 (1997).
123. Agosto MA, Ivanovic T, Nibert ML. Mammalia n reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl Acad. Sci. USA 103(44), 16496-16501 (2006).
124. Mainou BA, Dermody TS. Transport to late endosomes is required for efficient reovirus infection. J. Virol. 86(16), 8346-8358 (2012).
125. Nibert ML, Schiff LA, Fields BN. Mammalian reoviruses contain a myristoylated structural protein. J. Virol. 65(4), 1960-1967 (1991).
126. Lopez S, Arias CF. Early steps in rotavirus cell entry. Curr. Top. Microbiol. Immunol. 309, 39-66 (2006).
127. Sanchez-San Mart in C, Lopez T, Arias CF, Lopez S. Characterization of rotavirus cell entry. J. Virol. 78(5), 2310-2318 (2004).
128. I͉a P, Realpe M, Romero P, López S, Arias CF. Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology 322(2), 370-381 (2004).
129. Arias CF, Isa P, Guerrero CA et al. Molecular biology of rotavirus cell entry. Arch. Med. Res. 33, 356-361 (2002).
130. Diaz-Salinas MA, Romero P, Espinosa R, Hoshino Y, Lopez S, Arias CF. The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J. Virol. 87(3), 1658-1663 (2013).
131. Dowling W, Denisova E, LaMonica R , Mackow ER. Selective membrane permeabilization by the rotavirus VP5 protein is abrogated by mutations in an internal hydrophobic domain. J. Virol. 74(14), 6368-6376 (2000).
132. Denisova E, Dowling W, LaMonica R et al. Rotavirus capsid protein VP5 permeabilizes membranes. J. Virol. 73(4), 3147-3153 (1999).
133. Ciarlet M, Crawford SE, Che ng E et al. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J. Virol. 76(3), 1109-1123 (2002).
134. He Y, Bowman V, Mueller S et al. Interaction of the poliovirus receptor with poliovirus. Proc. Natl Acad. Sci. USA 97(1), 74-84 (2000).
135. Kirchner E, Guglielmi KM, Strauss HM, Dermody TS, Stehle T. Structure of reovirus 1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog. 4(12), e1000235 (2008).
136. Leiman PG, Shneider MM. Contractile tail machines of bacteriophages. In: Viral Molecular Machines. Rossmann MG, Rao VB (Eds). Springer US, Boston, MA, USA (2011
137. Davidson AR, Cardarelli L, Pell LG, Radford DR, Maxwell KL. Long noncontractile tail machines of bacteriophages In: Viral Molecular Machines. Rossmann MG, Rao VB (Eds). Springer US, Boston, MA, USA (2011).
138. Casjens SR, Molineux IJ. Short noncontractile tail machines: adsorption and DNA delivery by podoviruses. In: Viral Molecular Machines. Rossmann MG, Rao VB (Eds). Springer US, Boston, MA, USA (2011).
139. Cuzange A,Chroboczek J,Jacrot B The penton base of human adenovirus type 3 has the RGD motif Gene 146 2 257-259 1994).
140. Fox G, Parry N, Barnett P, McGinn B, Rowlands D, Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence rgd (arginineglycine-aspartic acid). J. Gen. Virol. 70, 625-637 (1989).
141. Joyce J, Tung J-S, Przysiecki C et al. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interact s with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274(9), 5810-5822 (1999).
142. Jackson T, Ellard F, Abu Ghazaleh R et al. Efficient infection of cells in culture by type o foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70(8), 5282-5287 (1996).
143. Kern A, Schmidt K, Leder C et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 77(20), 11072-11081 (2003).
144. Nemerow GR , Stewart PL. Antibody neutralization epitopes and integrin binding sites on nonenveloped viruses. Virology 288(2), 189-191 (2001).
145. Neu U, Bauer J, Stehle T. Viruses and sialic acids: rules of engagement. Curr. Opin. Struct. Biol. 21(5), 610-618 (2011).
146. Opie SR, Warrington KH, Agbandje-McKenna M, Zolotukhin S, Muzyczka N. Identification of amino acid residues in t he capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 77(12), 6995-7006 (2003).
147. Stehle T, Khan ZM. Rules and exceptions: sialic acid variants and their role in determining viral tropism. J. Virol. 88(14), 7696-7699 (2014).
148. Zhang P, Mueller S, Morais MC et al. Crystal structure of CD155 and electron microscopic s tudies of its complexes with polioviruses. Proc. Natl Acad. Sci. USA 105(47), 18284-18289 (2008).
149. Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12, 575-625 (1996).
150. Duan D, Li Q, Kao AW, Yue Y, Pessin JE, Engelhardt JF. Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73(12), 10371-10376 (1999).
151. Misinzo G, Meerts P, Bublot M, Mast J, Weingartl HM, Nauwynck HJ. Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4/31. J. Gen. Virol. 86(7), 2057-2068 (2005).
152. Nemerow GR, Stewart PL. Role of v integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 63(3), 725-734 (1999).
153. Pho MT, Ashok A, Atwood WJ. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 74(5), 2288-2292 (2000).
154. Stuart AD, Brown TDK. Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes. J. Virol. 80(15), 7500-7509 (2006).
155. Douar A-M, Poulard K, Stockholm D, Danos O. Intracellular traf ficking of adenoassociated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75(4), 1824-1833 (2001).
156. Ding W, Zhang L, Yeaman C, Engelhardt J. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion. Mol. Ther. 13(4), 671-682 (2006).
157. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191(3), 615-629 (2010).
158. Marjomaki V, Pietiainen V, Matilainen H et al. Internalization of echovirus 1 in caveolae. J. Virol. 76(4), 1856-1865 (2002).
159. Upla P, Marjoma ki V, Kankaanpaa P et al. Clustering induces a lateral redistribution of alpha2beta1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent Internalization. Mol. Biol. Cell 15, 625-636 (2004).
160. Anderson HA,Chen Y,Norkin LC Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7 11 1825-1834 1996).
161. Hummeler K, Tomassini N, Sokol F. Morphological aspects of the uptake of simian virus 40 by permissive cells. J. Virol. 6(1), 87-93 (1970).
162. Karten beck J, Stukenbrok H, Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J. Cell Biol. 109(6), 2721-2729 (1989).
163. Maul GG, Rovera G, Vorbrodt A, Abramczuk J. Membrane fusion as a mechanism of simian virus 40 entry into different cellular compartments. J. Virol. 28(3), 936-944 (1978).
164. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A. Ca veolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 76(10), 5156-5166 (2002).
165. Richards AA, Stang E, Pepperkok R, Parton RG. Inhibitors of COP-mediated transport and cholera toxin action inhibit simian virus 40 infection. Mol. Biol. Cell 13(5), 1750-1764 (2002).
166. Engel S, Heger T, Man cini R et al. Role of endosomes in simian virus 40 entry and infection. J. Virol. 85(9), 4198-4211 (2011).
167. Goodwin EC, Lipovsky A, Inoue T et al. BiP and multiple DNAJ molecular chaperones in the endoplasmic reticulum are required for efficient simian virus 40 infection. mBio 2(3), e00101-11-e00101-11 (2011) .
168. Geiger R, Andritschke D, Friebe S et al. BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nat. Cell Biol. 13(11), 1305-1314 (2011).
169. Schelhaas M, Malmström J, Pelkmans L et al. Simian virus 40 depends on er protein folding and quality control factors for entry into host cells. Cell 131(3), 516-529 (2007).
170. Kerr MC, Teasdale RD. Defining macropinocytosis. Traffic 10(4), 364-371 (2009).
171. Swanson J, Watts C. Macropinocytosis. Trends Cell Biol. 5, 424-428 (1995).
172. Mercer J, Helenius A. Virus entry by macropinocytosis. Nat. Cell Biol. 11(5), 510-520 (2009).
173. Krieger SE, Kim C, Zhang L, Marjomaki V, Bergelson JM. Echovirus 1 entry into polarized caco-2 cells depends on dynamin, cholesterol, and cellular factors associated with macropinocytosis. J. Virol. 87(16), 8884-8895 (2013).
174. Karjalainen M, Kakkonen E, Upla P et al. A Raft-derived, Pak1-regulated entry participates in alpha2beta1 integrindependent sorting to caveosomes. Mol. Biol. Cell 19, 2857-2869 (2008).
175. Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255(5052), 1718-1720 (1992).
176. Mayor S, Pagano RE. Pathways of clathrinindependent endocytosis. Nat. Rev. Mol. Cell Biol. 8(8), 603-612 (2007).
177. Sieczkarski SB, Whit taker GR. Dissecting virus entry via endocytosis. J. Gen. Virol. 83(7), 1535-1545 (2002).
178. Gerondopoulos A, Jackson T, Monaghan P, Doyle N, Roberts LO. Murine norovirus-1 cell entry i s mediated through a nonclathrin-, non-caveolae-, dynamin-and cholesterol-dependent pathway. J. Gen. Virol. 91(6), 1428-1438 (2010).
179. Guerrero CA, Zarate S, Corkidi G, Lopez S, Arias CF. Biochemical characterization of rotavirus receptors in MA104 cells. J. Virol. 74(20), 9362-9371 (2000).
180. Borsa J, Sargent MD, Lievaart PA, Copps TP. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111(1), 191-200 (1981).
181. Schulz WL, Haj AK, Schiff LA. Reovirus uses multiple endocytic pathways for cell entry. J. Virol. 86(23), 12665-12675 (2012).
182. Borsa J,Morash BD,Sargent MD,Copps TP,Lievaart PA,Szekely JG Two modes of entry of reovirus particles into L cells. J. Gen. Virol. 45, 161-170 1979).
183. Gilbert JM, Benjamin TL. Early steps of polyomavirus entry into cells. J. Virol. 74(18), 8582-8588 (2000).
184. Banerjee M, Johnson J.Activation, exposure and penetration of virally encoded, membrane-active polypeptides during non-enveloped virus entry. Curr. Protein Pept. Sci. 9(1), 16-27 (2008).
185. Agosto MA, Ivanovic T, Nibert ML. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl Acad. Sci. USA 103(44), 16496-16501 (2006).
186. Girod A, Wobus CE, Zádori Z et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol. 83(5), 973-978 (2002).
187. Bong DT, Steinern C, Janshoff A, Johnson JE, Reza Ghadiri M. A highly membraneactive peptide in Flock House virus: implications for the mechanism of nodavirus infection. Chem. Biol. 6(7), 473-4 81 (1999).
188. Maia LF, Soares MR, Valente AP et al. Structure of a membrane-binding domain from a non-enveloped animal virus: insights into the mechanism of membrane permeability and cellular entry. J. Biol. Che m. 281(39), 29278-29286 (2006).
189. Odegard AL, Chandran K, Zhang X, Parker JSL, Baker TS, Nibert ML. Putative autocleavage of outer capsid protein 1, allowing release of myristoylated pepti de 1N during particle uncoating, is critical for cell entry by reovirus. J. Virol. 78(16), 8732-8745 (2004).
190. Chappell JD, Gunn VL, Wetzel JD, Baer GS, Dermody TS. Mutations in type 3 reov irus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J. Virol. 71(3), 1834-1841 (1997).
191. Chappell JD, Prota AE, Dermody TS, Stehle T. Crystal structure of reovirus attachment protein 1 reveals evolutionary relationship to adenovirus fiber. EMBO J. 21(1-2), 1-11 (2002).
192. Forrest JC, Campbell J, Schelling P, Stehle T, Dermody T. Structure-function analysis of reovirus binding to junctional adhesion molecule 1: implications for the mechanism of reovirus attachment. J. Biol. Chem. 278(48), 48434-48444 (2003).
193. Maginnis MS, Mainou BA, Derdowski A, Johnson EM, Zent R, Dermody TS. NPXY motifs in the 1 integrin cytoplasmic tail are required for functional reovirus entry. J. Virol. 82(7), 3181-3191 (2008).
194. Reiss K, Stencel JE, Liu Y et al. The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog. 8(12), e1003078 (2012).
195. Reiter DM, Friers on JM, Halvorson EE, Kobayashi T, Dermody TS, Stehle T. Crystal structure of reovirus attachment protein 1 in complex with sialylated oligosaccharides. PLoS Pathog. 7(8), e1002166 (2011).
196. Rubin D, Weiner D, Dworkin C, Greene M, Maul G, Williams W. Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions. Microb. Pa thog. 12, 351-365 (1992).
197. Ebert DH, Deussing J, Peters C, Dermody TS. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277(27), 24609-24617 (2002).
198. Chandran K, Farsetta DL, Nibert ML. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein 1 mediates membrane disruption. J. Virol.76(19), 9920-9933 (2002).
199. Chandran K, Parker JSL, Ehrlich M, Kirchhausen T, Nibert ML. The region of outer-capsid protein 1 undergoes conformational change and release from reovirus particles during cell entry. J. Virol. 77(24 ), 13361-13375 (2003).
200. Nibert ML, Odegard AL, Agosto MA, Chandran K, Schiff LA. Putative autocleavage of reovirus 1 protein in concert with outer-capsid disassembly and activation for membrane per meabilization. J. Mol. Biol. 345(3), 461-474 (2005).
201. Ivanovic T, Agosto MA, Chandran K, Nibert ML. A role for molecular chaperone Hsc70 in reovirus outer capsid disassembly. J. Biol. Chem. 282(16), 12210-12219 (2007).
202. Roelvink PW, Lee GM, Einfeld D, Kovesdi I, Wickham T. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286(5444), 1568-1571 (1999).
203. Stewart P,Dermody T,Nemerow G Structural basis of nonenveloped virus cell entry. Adv. Protein Chem. 64, 455-491 2003).
204. Nakano MY, Boucke K, Suomalainen M, Stidwill RP, Greber UF. The First step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 74( 15), 7085-7095 (2000).
205. Seth P, FitzGerald DJ, Willingham MC, Pastan I. Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conj ugate. J. Virol. 51(3), 650-655 (1984).
206. Seth P, Pastan I, Willingham MC. Adenovirus-dependent changes in cell membrane permeability: role of Na+, K+-ATPase. J. Virol. 61(3), 883-888 (1987).
207. Burckhardt CJ, Suomalainen M, Schoenenberger P, Boucke K, Hemmi S, Greber UF. Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane l ytic protein exposure. Cell Host Microbe 10(2), 105-117 (2011).
208. Wodrich H, Cassany A, D'Angelo MA, Guan T, Nemerow G, Gerace L. Adenovirus core protein pVII is translocated int o the nucleus by multiple import receptor pathways. J. Virol. 80(19), 9608-9618 (2006).
209. Suomalainen M, Nakano MY, Keller S, Boucke K, Stidwill RP, Greber UF. Microtubule-dependen t plus-and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144(4), 657-672 (1999).
210. Kelkar SA, Pfister KK, Crystal RG, Leopold PL. Cytoplasmic dynein mediates adenovirus binding to microtubules. J. Virol. 78(18), 10122-10132 (2004).
211. Cohen S, Au S, Panté N. How viruses access the nucleus. Biochim. Biophys. Acta BBA Mol. Cell Res. 1813(9), 1634-1645 (2011).
212. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16(19), 5998-6007 (1997).
213. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3(12), 1092-1100 (2001 ).
214. Wisnivesky JP, Leopold PL, Crystal RG. Specific binding of the adenovirus capsid to the nuclear envelope. Hum. Gene Ther. 10(13), 2187-2195 (1999).
215. Baek S-H, Kwa k J-Y, Lee SH et al. Lipase activities of p37, the major envelope protein of vaccinia virus. J. Biol. Chem. 272(51), 32042-32049 (1997).
216. Koonin EV. A duplicated catalytic motif in a new supe rfamily of phosphohydrolases and phospholipid synthases that includes poxvirus envelope proteins. Trends Biochem. Sci. 21(7), 242-243 (1996).
217. Pointing CP, Kerr ID. A novel family of phospholipase D h omologues that includes phospholipid synthases and putative endonucleases: Identification of duplicated repeats and potential active site residues. Protein Sci. 5, 914-922 (1996).
218. Sung T-C, Roper RL, Zhang Y et al. Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J. 16(15), 4519-4530 (1997).
219. Kamil JP, Tis cher BK, Trapp S, Nair VK, Osterrieder N, Kung H-J. vLIP, a viral lipase homologue, is a virulence factor of Marek's Disease Virus. J. Virol. 79(11), 6984-6996 (2005).
220. Kaludov N, Bro wn KE, Walters RW, Zabner J, Chiorini JA. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75(15), 6884-6893 (2001).
221. Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75(9), 4080-4090 (2001).
222. Dorsch S, Liebisch G, Kaufmann B et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 76(4), 2014-2018 (2002).
223. Venkatakrishnan B, Yarbrough J, Domsic J et al. Structure and dynamics of adeno associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. J. Virol. 87(9), 4974-4984 (2013).
224. Sonntag F,Bleker S,Leuchs B,Fischer R,Kleinschmidt JA Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains a re generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus J. Virol. 80 22 11040-11054 2006).
225. Akache B, Grimm D, Shen X et al. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adenoassociated virus 2 and 8. Mol. Ther. 15(2), 330-339 (2007).
226. Seisenberger G, Reid M, Endress T, Buning H, Hallek M, Brauchle C. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science 294(5548), 1929-1932 (2001).
227. Nakagawa H, Arisaka F, Ishii S-I. Isolation and characterization of the bacteriophage T4 tail-associated lysozyme. J. Virol. 54(2), 460-466 (1985).
228. Leiman PG, Chipman PR, Kostyuchenko VA, Mesyanzhinov VV, Rossmann MG. Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host. Cell 118(4), 419-429 (2004).
229. Kan amaru S, Leiman P, Kostyuchenko V et al. Structure of the cell-puncturing device of bacteriophage T4. Nature 415(6871), 553-557 (2002).
230. Nishima W, Kanamaru S, Arisaka F, Kitao A. Screw motion regulates multiple functions of T4 phage protein gene product 5 during cell puncturing. J. Am. Chem. Soc. 133(34), 13571-13576 (2011).
231. Suzuki R, Inagaki M, Karita S et al. Specific interaction of fused H protein of bacteriophage phiX174 with receptor lipopolysaccharides. Virus Res. 60, 95-99 (1999).
232. Sun L, Young LN, Zhang X et al. Icosahedral bacteriophage X174 forms a tail for DNA transport during infection. Nature 505(7483), 432-435 (2014).
233. Bhella D, Gatherer D, Chaudhry Y, Pink R, Goodfellow IG. Structural insights into calicivirus attachment and uncoating. J. Virol. 82(16), 8051-8058 (2008).
234. Cavaldesi M, Caruso M, Sthandier O, Amati P, Garcia M. Conformational changes of murine polyomavirus capsid protein s induced by sialic acid binding. J. Biol. Chem. 279(40), 41573-41579 (2004).
235. Fernandes J, Tang D, Leone G, Lee PW. Binding of reovirus to receptor leads to conformational changes in viral ca psid proteins that are reversible upon virus detachment. J. Biol. Chem. 269(25), 17043-17047 (1994).
236. Hogle JM. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu. Rev. Microbiol. 56(1), 677-702 (2002).
237. Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. Interaction with coxsackievirus and adenovirus receptor, but not with decayacc elerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79(1), 655-660 (2005).
238. Selinka H-C, Giroglou T, Nowak T, Christensen ND, Sapp M. Further evidence that papillomavirus capsids exist in two distinct conformations. J. Virol. 77(24), 12961-12967 (2003).
239. Odegard AL, Kwan MH, Walukiewicz HE, Banerjee M, Schneemann A , Johnson JE. Low endocytic pH and capsid protein autocleavage are critical components of flock house virus cell entry. J. Virol. 83(17), 8628-8637 (2009).
240. Crawford SE, Mukherjee SK, Est es MK et al. Trypsin cleavage stabilizes the rotavirus VP4 spike. J. Virol. 75(13), 6052-6061 (2001).
241. Chromy LR, Oltman A, Estes PA, Garcea RL. Chaperone-mediated in vitro disassembly of polyoma-and papillomaviruses. J. Virol. 80(10), 5086-5091 (2006).
242. Magnuson B, Rainey EK, Benjamin T, Baryshev M, Mkrtchian S, Tsai B. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell. 20(2), 289-300 (2005).